Savage Margaret C, Bliss Geraldine, Buxbaum Joseph D, Farrell Jordan S, Levin April R, Srivastava Siddharth, Berry-Kravis Elizabeth, Holder J Lloyd, Sahin Mustafa
Department of Neurology, Harvard Medical School, Boston, MA, USA.
CureSHANK, Beverly Hills, CA, USA.
Ther Adv Rare Dis. 2024 Sep 5;5:26330040241273464. doi: 10.1177/26330040241273464. eCollection 2024 Jan-Dec.
On September 27, 2023, the CureSHANK nonprofit foundation sponsored a conference in Boston, Massachusetts, to identify gaps in knowledge surrounding SHANK3-related epilepsy with the goal of determining future research priorities and recommendations. In addition to patient families and members of the CureSHANK community, participants in the conference included a broad cross-section of preclinical and clinical researchers and clinicians with expertise in SHANK3-related epilepsy as well as representatives from the pharmaceutical industry. Here we summarize the outcomes from comprehensive premeeting deliberations and the final conference recommendations, including (1) gaps in knowledge related to clinical science, (2) gaps in knowledge related to preclinical science, and (3) research priorities moving forward.
2023年9月27日,CureSHANK非营利基金会在马萨诸塞州波士顿主办了一次会议,以找出围绕与SHANK3相关的癫痫的知识空白,目标是确定未来的研究重点和建议。除了患者家庭和CureSHANK社区成员外,会议参与者还包括广泛的临床前和临床研究人员以及在与SHANK3相关的癫痫方面具有专业知识的临床医生,以及制药行业的代表。在此,我们总结会前全面审议的结果和会议的最终建议,包括(1)与临床科学相关的知识空白,(2)与临床前科学相关的知识空白,以及(3)未来的研究重点。